Lanthanum Carbonate Chewable Tablets, 1000mg, 10-count bottle, Rx only, Manufactured for Cipla USA, NDC 69097-0936-98
Published November 20, 2024 · Recall initiated: October 23, 2024
Summary
FDA records drug Class II recall D-0043-2025, published November 20, 2024 and initiated October 23, 2024. Recalling firm: Cipla USA, Inc.; Status: Ongoing; Reported quantity: 1,875 boxes (cipla and exlan); Lot: Lot # NB240316, Exp 12/31/25. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Tablet/Capsule Specifications: Complaints received of crushed and broken tablets.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Cipla USA, Inc.
- Distributor
- USA nationwide.
- Lot
- Lot # NB240316, Exp 12/31/25
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAFosfomycin Tromethamine Granules for Oral Solution, (Equivalent to 3 Grams of Fosfomycin), 1 Single-DoseOctober 14, 2026
- FDACinacalcet Hydrochloride Tablets, 30 mg, 30-count bottle, Rx Only, Manufactured by: Cipla Ltd., MIDC,July 8, 2026
- FDACinacalcet Hydrochloride Tablets, 60 mg, 30-count bottle, Rx Only, Manufactured by: Cipla Ltd., MIDC,July 8, 2026
- FDACinacalcet Hydrochloride Tablets, 90 mg, 30-count bottle, Rx Only, Manufactured by: Cipla Ltd., MIDC,July 8, 2026
- FDATrinity Gold Nutrition, 60 Capsule, 30 day Supply, Distributed by Trinity Gold Nutrition 201 Tom Hall St. Ste.November 20, 2024
- FDALanthanum Carbonate Chewable Tablets, 1000mg, 10-count bottle, Rx only, Manufactured for ExelanNovember 20, 2024
Questions about this recall
Was Lanthanum Carbonate Chewable Tablets, 1000mg, 10-count bottle, Rx only, Manufactured for Cipla USA, NDC 69097-0936-98 recalled?
Yes. FDA published recall D-0043-2025 on November 20, 2024. Reported hazard: Failed Tablet/Capsule Specifications: Complaints received of crushed and broken tablets.
What should I do if I have this product?
Voluntary: Firm initiated · Letter